Evaluation of Cratos™ Branch Stent Graft System in Treatment of Descending Aorta Lesions
The goal of this prospective, interventional, multicentre, single-arm performance objective study is to evaluate efficacy and safety of Cratos™ Branch Stent Graft System in treatment of lesions (dissection, IMH and PAU in descending aorta. The main question[s] it aims to answer are:
30-day all-cause Mortality rate
Composite of the following events from the time of enrolment through 12-month:
Device Technical Success
Absence of: Aortic rupture, Lesion-related mortality, Disabling Stroke, Permanent paraplegia, Permanent paraparesis, New onset renal failure requiring permanent dialysis, Additional unanticipated post-procedural surgical or interventional procedure related to the device, procedure, or withdrawal of the device system
Participants will come for hospital office visits 1, 6, 12, 24-, 36-, 48- and 60-months post-procedure for the following, but not limited to assessments:
Physical examination
Modified Rankin scale
Tarlov scoring scale
CTA
100 Clinical Results associated with Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd.
0 Patents (Medical) associated with Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd.
100 Deals associated with Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd.
100 Translational Medicine associated with Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd.